Drug Usability Survey (DUS) of Gabapentinoid and Its Combinations Among Indian Patients With Neuropathic Pain: Results From a Real-World, Multicenter, Retrospective Survey at Neurology Clinics
Gabapentinoid-based treatments combined with TCA and SSNRI are useful and well-accepted treatment modalities by neurologists in painful neuropathies. Gabapentinoids are non-opioids with no risk of abuse and addiction and were considered the first line of therapy for various types of neuropathic pain.
Authors
- Siraj Ahmed Khan (ORCID: https://orcid.org/0000-0002-5142-7691)
- Prashant K. Deshmukh (ORCID: https://orcid.org/0000-0001-8862-7286)
- Maneesha Khalse (ORCID: https://orcid.org/0000-0002-8613-6448)
- Kamlesh Patel (ORCID: https://orcid.org/0000-0002-3752-9544)
- Puneet Aggarwal (ORCID: https://orcid.org/0000-0002-7200-1569)
- P. Mishra
- V N Mathur
- Kiran C Velivela
Institutions
- Guntur Medical College (IN)
- Lupin Pharmaceuticals (India) (IN)
- Max Super Speciality Hospital (IN)
- Apollo KH Hospital (IN)
- Indo-US Super Speciality Hospital (IN)
- Maternity Foundation (DK)
Publication Details
- Journal
- Cureus
- Published
- 2025-02-26
- DOI
- https://doi.org/10.7759/cureus.79722
- Primary Topic
- Pain Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00